Skip Navigation
Search Menu
Find an Expert

 


Michael Patrick Boyle, M.D.

Photo of Dr. Michael Patrick Boyle, M.D.

Male

Expertise: Cystic Fibrosis, Adult, Lung Transplant, Pulmonary Disease and Critical Care Medicine

Research Interests: CFTR Modulators; Cystic Fibrosis Clinical Trials; Difficult to Treat Infections in Cystic Fibrosis

Request an Appointment

I live in Maryland

410-955-3467
Request an appointment through MyChart!

I live outside of Maryland

410-464-6641
Request Appointment

I live outside of the United States

+1-410-502-7683
Request Appointment

Locations

The Johns Hopkins Hospital
Appointment Phone: 410-955-3467

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map

Johns Hopkins Bayview Medical Center
Appointment Phone: 410-550-5864

4940 Eastern Avenue
Baltimore, MD 21224 map

Contact for Research Inquiries

1830 E. Monument Street, 5th floor
Division of Pulmonary and Critical Care Medicine
Baltimore, MD 21205 map

Background

Dr. Michael Boyle is an Adjunct Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of expertise include adult cystic fibrosis care and research, lung transplantation and pulmonary diseases. 

Dr. Boyle founded and then directed the Johns Hopkins Adult Cystic Fibrosis Program from 1999 to 2015 at the Johns Hopkins Cystic Fibrosis Center. He is now Senior Vice President for Therapeutics Development at the U.S. Cystic Fibrosis Foundation and Adjunct Johns Hopkins faculty member. His research is focused on clinical trials for the development of new cystic fibrosis therapies. 

Dr. Boyle completed all of his medical training at Johns Hopkins including fellowship in pulmonary and critical care medicine before joining the Johns Hopkins faculty in 1999. He is internationally known both for his clinical research in CFTR modulators and for his work to improve care for adults with cystic fibrosis.  While at Johns Hopkins he has received numerous honors including the American Lung Association’s George Comstock Career Achievement Award, American Federation of Clinical Research Achievement Award, “Patient’s Choice Award”, “Best Teacher”, and “Best Doctors in America”.

...read more

Departments / Divisions

Education

Degrees

  • MD, Johns Hopkins University School of Medicine (1991)

Residencies

  • Johns Hopkins University School of Medicine / Internal Medicine (1994)

Fellowships

  • Johns Hopkins University School of Medicine / Pulmonary and Critical Care Medicine (1999)

Board Certifications

  • American Board of Internal Medicine / Pulmonary Disease (1999, 2009)

Research & Publications

Research Summary

Dr. Boyle is internationally known for his clinical research in both CFTR modulators and difficult to treat lung infections.  He has been the principal investigator for international clinical trials of CFTR modulator therapies which resulted in approval of new therapies for individuals with cystic fibrosis.

Selected Publications

View all on Pubmed

Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med. 373:220-31, 2015. PMID: 25981758

Boyle MP, Bell SC, Konstan MW, McColley SA, Rowe SM, Rietschel E, Huang X, Waltz D, Patel NR, Rodman D. on behalf of the VX09-809-102 Study Group. Randomised Trial of Combined CFTR Corrector and Potentiator Therapy in F508del-CFTR Cystic Fibrosis. The Lancet – Respiratory Medicine. 2: 527-38, 2014. PMID: 24973281

Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association of Respiratory Tract Methicillin-Resistant Staphylococcus Aureus and Survival in Cystic Fibrosis. JAMA 303:2386-92, 2010. PMID: 20551409

Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistent Methicillin-resistant Staphylococcus Aureus and Rate of FEV1 Decline in Cystic Fibrosis. Am J Respir Crit Care Med 178:814-821; 2008. PMID: 18669817

Boyle MP, Sabadosa KA, Quinton HB, Marshall BC, Schechter MS. Key Findings of the Cystic Fibrosis Foundation's U.S. Clinical Practice Benchmarking Project. BMJ Quality and Safety. 23:15-22, 2014. PMID: 24608546

Activities & Honors

Honors

  • Best Doctors in America
  • Alpha Omega Alpha (AOA), Johns Hopkins Chapter, 2006

Professional Activities

  • Senior Vice President of Therapeutics Development, Cystic Fibrosis Foundation, 2015
Is this you? Edit Profile